IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Proteon Therapeutics Inc

CUSIP: 74371L109 | 101 institutional holders

Quarters

Q3 2020Q1 2020Q4 2019Q3 2019Q2 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2020

Abingworth LLP20,610
0.1% of portfolio›$344
StyleTurnoverLocationFiled
Abingworth LLP
20,610$3440.1%N/AN/ALondon, United Kingdom2020-11-16